G
The Firm Fixed PO will include the following:
1. Meso Scale Discovery V-PLEX Custom Human Cytokine (25 Plate)
- K151AOH-4; &
2. Meso Scale Discovery U-PLEX Biomaker Group 1 (hu) Assays, SECTOR (25 Plate)
- K15067L-4:
Meso Scale Discovery V-PLEX Custom Human Cytokine (25 Plate) - K151AOH-4:
V-PLEX validated assays deliver reproducibility and reliability to support long-term studies. V-PLEX assays maximize consistency in results and confidence in data. The V-PLEX Custom Human Cytokine panel is configured for assay performance and reproducibility. Users are able to select specific targets of interest to measure. Developed under design control and according to the FDA's analytical validation guidelines, V-PLEX represents the highest quality assay available from MSD. Comprehensive testing of all raw materials and kit components combined with rigorous manufacturing and QC specifications ensure reproducible results. All V-PLEX kits come with coated MULTI-SPOT plates, calibrators, individual labeled detection antibodies, optimized diluents, a comprehensive product insert, and a certificate of analysis.
Meso Scale Discovery U-PLEX Biomarker Group 1 (hu) Assays, SECTOR (25 Plate) - K15067L-4:
U-PLEX assays are offered as fully customizable groups that include a broad menu of analytes assembled together by species, sample abundance, analytical compatibility, range in serum and plasma samples, and expected use. The U-PLEX Biomarker Group 1 panel is a custom combination of analytes from a selection of MSD® assays. The U-PLEX Biomarker Group 1 (hu) contains 40 cytokines and chemokines that are important in many biological processes.
USDA ARS, WHNRC is attaining these Reagents for their ongoing human study research and must continue using the same cytokine kits & assays with the MESO Instrument (USDA purchased & owned) to maintain consistency.
Pursuant to the authority of 41 U.S.C. 253(c)(1) and FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
The award date will be on or about August 24, 2016; and this Notice of Intent is not considered as a Request for Quotation (RFQ) nor is it a Request for Proposals (RFP). No solicitation document is available and telephone requests will not be honored. Interested persons may identify their interest and capability to respond to this requirement. A determination, by the Government, to compete this proposed PO based on responses to this notice is solely within the discretion of the Government. The Government will consider all responses received by 10:30AM PST, August 24, 2016. Information received will be considered solely for determining whether to conduct a competitive procurement. Inquiries will only be accepted via email to the Primary Point of Contact: [email protected].